Efficacy and safety of topiramate in infants according to epilepsy syndromes

S. Grosso, D. Galimberti, M. A. Farnetani, M. Cioni, R. Mostardini, R. Vivarelli, R. M. Di Bartolo, E. Bernardoni, R. Berardi, G. Morgese, P. Balestri

Research output: Contribution to journalArticle

Abstract

Studies of the efficacy of topiramate (TPM) in infants and young children are few. Here we report an open, prospective, and pragmatic study of effectiveness of TPM in terms of epilepsy syndromes, in children aged less than 2 years. The median follow-up period was 11 months. We enrolled 59 children in the study: 22 affected by localization-related epilepsy (LRE), 23 by generalized epilepsy, six by Dravet's syndrome, and eight with unclassifiable epilepsy. TPM was effective (responders showed a decrease of more than 50% in seizure frequency) in 47% of patients, including 13% who were seizure-free at the last visit. TPM was more effective in localization-related epilepsy (48% of responders) than in generalized epilepsy (32% of responders). In the latter group, 19 patients suffered from infantile spasms. Four of six patients with cryptogenic infantile spasms became seizure-free. Of the 13 patients with symptomatic infantile spasms, only one was seizure-free. Results were poor for patients with Dravet's syndrome. In general, TPM was well tolerated. The most frequently reported adverse effects were drowsiness, irritability, hyperthermia, and anorexia. The present study concludes that TPM is effective for a broad range of seizures in infants and young children and represents a valid therapeutic option in this population.

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalSeizure
Volume14
Issue number3
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Epilepsy
Seizures
Safety
Infantile Spasms
Myoclonic Epilepsy
Generalized Epilepsy
Partial Epilepsy
Sleep Stages
Anorexia
topiramate
Fever
Prospective Studies
Population
Therapeutics

Keywords

  • Antiepileptic drugs
  • Drug resistant epilepsy
  • Epilepsy syndrome
  • Infantile spasms
  • Topiramate

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Psychology(all)

Cite this

Grosso, S., Galimberti, D., Farnetani, M. A., Cioni, M., Mostardini, R., Vivarelli, R., ... Balestri, P. (2005). Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure, 14(3), 183-189. https://doi.org/10.1016/j.seizure.2005.01.006

Efficacy and safety of topiramate in infants according to epilepsy syndromes. / Grosso, S.; Galimberti, D.; Farnetani, M. A.; Cioni, M.; Mostardini, R.; Vivarelli, R.; Di Bartolo, R. M.; Bernardoni, E.; Berardi, R.; Morgese, G.; Balestri, P.

In: Seizure, Vol. 14, No. 3, 04.2005, p. 183-189.

Research output: Contribution to journalArticle

Grosso, S, Galimberti, D, Farnetani, MA, Cioni, M, Mostardini, R, Vivarelli, R, Di Bartolo, RM, Bernardoni, E, Berardi, R, Morgese, G & Balestri, P 2005, 'Efficacy and safety of topiramate in infants according to epilepsy syndromes', Seizure, vol. 14, no. 3, pp. 183-189. https://doi.org/10.1016/j.seizure.2005.01.006
Grosso, S. ; Galimberti, D. ; Farnetani, M. A. ; Cioni, M. ; Mostardini, R. ; Vivarelli, R. ; Di Bartolo, R. M. ; Bernardoni, E. ; Berardi, R. ; Morgese, G. ; Balestri, P. / Efficacy and safety of topiramate in infants according to epilepsy syndromes. In: Seizure. 2005 ; Vol. 14, No. 3. pp. 183-189.
@article{af0bfc9b0bef4335beb8fdfa5a0f342c,
title = "Efficacy and safety of topiramate in infants according to epilepsy syndromes",
abstract = "Studies of the efficacy of topiramate (TPM) in infants and young children are few. Here we report an open, prospective, and pragmatic study of effectiveness of TPM in terms of epilepsy syndromes, in children aged less than 2 years. The median follow-up period was 11 months. We enrolled 59 children in the study: 22 affected by localization-related epilepsy (LRE), 23 by generalized epilepsy, six by Dravet's syndrome, and eight with unclassifiable epilepsy. TPM was effective (responders showed a decrease of more than 50{\%} in seizure frequency) in 47{\%} of patients, including 13{\%} who were seizure-free at the last visit. TPM was more effective in localization-related epilepsy (48{\%} of responders) than in generalized epilepsy (32{\%} of responders). In the latter group, 19 patients suffered from infantile spasms. Four of six patients with cryptogenic infantile spasms became seizure-free. Of the 13 patients with symptomatic infantile spasms, only one was seizure-free. Results were poor for patients with Dravet's syndrome. In general, TPM was well tolerated. The most frequently reported adverse effects were drowsiness, irritability, hyperthermia, and anorexia. The present study concludes that TPM is effective for a broad range of seizures in infants and young children and represents a valid therapeutic option in this population.",
keywords = "Antiepileptic drugs, Drug resistant epilepsy, Epilepsy syndrome, Infantile spasms, Topiramate",
author = "S. Grosso and D. Galimberti and Farnetani, {M. A.} and M. Cioni and R. Mostardini and R. Vivarelli and {Di Bartolo}, {R. M.} and E. Bernardoni and R. Berardi and G. Morgese and P. Balestri",
year = "2005",
month = "4",
doi = "10.1016/j.seizure.2005.01.006",
language = "English",
volume = "14",
pages = "183--189",
journal = "Seizure : the journal of the British Epilepsy Association",
issn = "1059-1311",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Efficacy and safety of topiramate in infants according to epilepsy syndromes

AU - Grosso, S.

AU - Galimberti, D.

AU - Farnetani, M. A.

AU - Cioni, M.

AU - Mostardini, R.

AU - Vivarelli, R.

AU - Di Bartolo, R. M.

AU - Bernardoni, E.

AU - Berardi, R.

AU - Morgese, G.

AU - Balestri, P.

PY - 2005/4

Y1 - 2005/4

N2 - Studies of the efficacy of topiramate (TPM) in infants and young children are few. Here we report an open, prospective, and pragmatic study of effectiveness of TPM in terms of epilepsy syndromes, in children aged less than 2 years. The median follow-up period was 11 months. We enrolled 59 children in the study: 22 affected by localization-related epilepsy (LRE), 23 by generalized epilepsy, six by Dravet's syndrome, and eight with unclassifiable epilepsy. TPM was effective (responders showed a decrease of more than 50% in seizure frequency) in 47% of patients, including 13% who were seizure-free at the last visit. TPM was more effective in localization-related epilepsy (48% of responders) than in generalized epilepsy (32% of responders). In the latter group, 19 patients suffered from infantile spasms. Four of six patients with cryptogenic infantile spasms became seizure-free. Of the 13 patients with symptomatic infantile spasms, only one was seizure-free. Results were poor for patients with Dravet's syndrome. In general, TPM was well tolerated. The most frequently reported adverse effects were drowsiness, irritability, hyperthermia, and anorexia. The present study concludes that TPM is effective for a broad range of seizures in infants and young children and represents a valid therapeutic option in this population.

AB - Studies of the efficacy of topiramate (TPM) in infants and young children are few. Here we report an open, prospective, and pragmatic study of effectiveness of TPM in terms of epilepsy syndromes, in children aged less than 2 years. The median follow-up period was 11 months. We enrolled 59 children in the study: 22 affected by localization-related epilepsy (LRE), 23 by generalized epilepsy, six by Dravet's syndrome, and eight with unclassifiable epilepsy. TPM was effective (responders showed a decrease of more than 50% in seizure frequency) in 47% of patients, including 13% who were seizure-free at the last visit. TPM was more effective in localization-related epilepsy (48% of responders) than in generalized epilepsy (32% of responders). In the latter group, 19 patients suffered from infantile spasms. Four of six patients with cryptogenic infantile spasms became seizure-free. Of the 13 patients with symptomatic infantile spasms, only one was seizure-free. Results were poor for patients with Dravet's syndrome. In general, TPM was well tolerated. The most frequently reported adverse effects were drowsiness, irritability, hyperthermia, and anorexia. The present study concludes that TPM is effective for a broad range of seizures in infants and young children and represents a valid therapeutic option in this population.

KW - Antiepileptic drugs

KW - Drug resistant epilepsy

KW - Epilepsy syndrome

KW - Infantile spasms

KW - Topiramate

UR - http://www.scopus.com/inward/record.url?scp=20144366554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144366554&partnerID=8YFLogxK

U2 - 10.1016/j.seizure.2005.01.006

DO - 10.1016/j.seizure.2005.01.006

M3 - Article

C2 - 15797353

AN - SCOPUS:20144366554

VL - 14

SP - 183

EP - 189

JO - Seizure : the journal of the British Epilepsy Association

JF - Seizure : the journal of the British Epilepsy Association

SN - 1059-1311

IS - 3

ER -